Latest News
The fall edition of the Alzheimer's Disease Research Review provides information on how improving brain blood flow could improve cognitive function in people who have Alzheimer's, the influence of genetics on Alzheimer's, a clinical trial examining the effects of physical activity on the dementia risk for older African Americans, and the uses and misuses of antipsychotic medications for managing challenging behaviors associated with Alzheimer's.
Advanced imaging that could lead to a screening test for Alzheimer’s disease (AD), circadian rhythms and their relationship to AD, the importance of clinical trials for developing new AD treatments, and part one of a three-part series on the challenging behaviors associated with AD are among the articles that you will find in the summer 2018 edition of the Alzheimer's Disease Research Review.
BrightFocus Foundation today announced that EyesOnALZ, the first-ever crowdsourced project to engage the public in Alzheimer’s research, hit a major milestone by exceeding 10,000 citizen scientists joining to help speed up the time-consuming data analysis of stalled blood vessels in the brain. BrightFocus is the key funder of this effort.
BrightFocus Foundation today announced $13.5 million in new scientific research grants seeking cures for Alzheimer’s disease, macular degeneration, and glaucoma.
The spring edition of Alzheimer's Disease Research Review provides information about a major advance in drug development that started with funding from Alzheimer's Disease Research (ADR), explains why clinical trial volunteers are key for curing Alzheimer’s, summarizes recommendations for home-based dementia care that were unveiled at an event sponsored by ADR, offers some tips and advice for informing your loved one about their Alzheimer’s diagnosis, and more.
Learn about a major study that sheds new light into the causes of Alzheimer's, an innovative Alzheimer's project that is (literally) out of this world, helpful tips for when Alzheimer's affects sleep, a Q&A on clinical trials with Dr. Mario Cornacchione, and more in the winter edition of the Alzheimer's Disease Research newsletter.
BrightFocus Foundation, a nonprofit and premier source of research funding to defeat Alzheimer’s, macular degeneration, and glaucoma, today was acknowledged as the catalyst behind a major advance in drug development for Alzheimer’s disease.
A panel of leading researchers and policy experts has released five key recommendations for public and private sector leaders to better support people with dementia living in their own home.